139 related articles for article (PubMed ID: 14602581)
21. Phospholipase C-gamma inhibition prevents EGF protection of intestinal cytoskeleton and barrier against oxidants.
Banan A; Fields JZ; Zhang Y; Keshavarzian A
Am J Physiol Gastrointest Liver Physiol; 2001 Aug; 281(2):G412-23. PubMed ID: 11447022
[TBL] [Abstract][Full Text] [Related]
22. Fucosyltransferase IV enhances expression of MMP-12 stimulated by EGF via the ERK1/2, p38 and NF-κB pathways in A431 cells.
Yang XS; Liu SA; Liu JW; Yan Q
Asian Pac J Cancer Prev; 2012; 13(4):1657-62. PubMed ID: 22799384
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha.
Sethi G; Ahn KS; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Nov; 26(52):7324-32. PubMed ID: 17533369
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel-induced immune suppression is associated with NF-kappaB activation via conventional PKC isotypes in lipopolysaccharide-stimulated 70Z/3 pre-B lymphocyte tumor cells.
Lee M; Jeon YJ
Mol Pharmacol; 2001 Feb; 59(2):248-53. PubMed ID: 11160860
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of tumor necrosis factor-alpha-induced leaks in intestine epithelial barrier.
He F; Peng J; Deng XL; Yang LF; Camara AD; Omran A; Wang GL; Wu LW; Zhang CL; Yin F
Cytokine; 2012 Aug; 59(2):264-72. PubMed ID: 22583690
[TBL] [Abstract][Full Text] [Related]
26. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
[TBL] [Abstract][Full Text] [Related]
27. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease.
Waris G; Livolsi A; Imbert V; Peyron JF; Siddiqui A
J Biol Chem; 2003 Oct; 278(42):40778-87. PubMed ID: 12909638
[TBL] [Abstract][Full Text] [Related]
29. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation.
Monteleone G; Mann J; Monteleone I; Vavassori P; Bremner R; Fantini M; Del Vecchio Blanco G; Tersigni R; Alessandroni L; Mann D; Pallone F; MacDonald TT
J Biol Chem; 2004 Feb; 279(6):3925-32. PubMed ID: 14600158
[TBL] [Abstract][Full Text] [Related]
30. Mercuric ion attenuates nuclear factor-kappaB activation and DNA binding in normal rat kidney epithelial cells: implications for mercury-induced nephrotoxicity.
Dieguez-Acuña FJ; Ellis ME; Kushleika J; Woods JS
Toxicol Appl Pharmacol; 2001 Jun; 173(3):176-87. PubMed ID: 11437639
[TBL] [Abstract][Full Text] [Related]
31. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
Roussel RR; Barchowsky A
Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
[TBL] [Abstract][Full Text] [Related]
32. Enhanced heat shock protein 70 expression alters proteasomal degradation of IkappaB kinase in experimental acute respiratory distress syndrome.
Weiss YG; Bromberg Z; Raj N; Raphael J; Goloubinoff P; Ben-Neriah Y; Deutschman CS
Crit Care Med; 2007 Sep; 35(9):2128-38. PubMed ID: 17855826
[TBL] [Abstract][Full Text] [Related]
33. PKC zeta participates in activation of inflammatory response induced by enteropathogenic E. coli.
Savkovic SD; Koutsouris A; Hecht G
Am J Physiol Cell Physiol; 2003 Sep; 285(3):C512-21. PubMed ID: 12900386
[TBL] [Abstract][Full Text] [Related]
34. Taxol selectively blocks microtubule dependent NF-kappaB activation by phorbol ester via inhibition of IkappaBalpha phosphorylation and degradation.
Spencer W; Kwon H; Crépieux P; Leclerc N; Lin R; Hiscott J
Oncogene; 1999 Jan; 18(2):495-505. PubMed ID: 9927206
[TBL] [Abstract][Full Text] [Related]
35. 1,25-dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IκBα via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells.
Song Y; Hong J; Liu D; Lin Q; Lai G
Scand J Immunol; 2013 Feb; 77(2):109-16. PubMed ID: 23126502
[TBL] [Abstract][Full Text] [Related]
36. EGF-induced dynamics of NF-κB and F-actin in A431 cells spread on fibronectin.
Bolshakova A; Magnusson KE; Pinaev G; Petukhova O
Histochem Cell Biol; 2015 Sep; 144(3):223-35. PubMed ID: 25990946
[TBL] [Abstract][Full Text] [Related]
37. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.
Huang L; Verstrepen L; Heyninck K; Wullaert A; Revets H; De Baetselier P; Beyaert R
Oncogene; 2008 Oct; 27(47):6131-40. PubMed ID: 18622428
[TBL] [Abstract][Full Text] [Related]
38. Disruption of the actin cytoskeleton results in nuclear factor-kappaB activation and inflammatory mediator production in cultured human intestinal epithelial cells.
Németh ZH; Deitch EA; Davidson MT; Szabó C; Vizi ES; Haskó G
J Cell Physiol; 2004 Jul; 200(1):71-81. PubMed ID: 15137059
[TBL] [Abstract][Full Text] [Related]
39. Involvement of kinase PKC-zeta in the p62/p62(P392L)-driven activation of NF-κB in human osteoclasts.
Chamoux E; McManus S; Laberge G; Bisson M; Roux S
Biochim Biophys Acta; 2013 Mar; 1832(3):475-84. PubMed ID: 23266528
[TBL] [Abstract][Full Text] [Related]
40. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import.
Mattioli I; Sebald A; Bucher C; Charles RP; Nakano H; Doi T; Kracht M; Schmitz ML
J Immunol; 2004 May; 172(10):6336-44. PubMed ID: 15128824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
